KremIQ by B3-MED in Forbes

Forbes published a feature on the growing scientific approach to choosing skincare products.

01 September 2026

In the article "Proof in the Face," KremIQ by B3-MED was featured as one of the Russian services leading this trend. The service analyzes cosmetic formulations, evaluates the evidence base for ingredients, takes into account the user's skin type and characteristics, and allows products to be compared side by side.

For the Forbes feature, the KremIQ team provided analysis results covering more than 12,000 popular cosmetic products available in Russia. The effectiveness ratings are based on clinical research data. The system also applies its own classification of 64 skin types.

KremIQ's research revealed a significant gap between marketing claims and the actual composition of some cosmetic products. In particular, 46% of the anti-aging products studied contained no ingredients with proven efficacy. The analysis also found no correlation between a product's high price and its effectiveness.

KremIQ's appearance in Forbes reflects growing interest from major media outlets and consumers in an evidence-based approach to cosmetics. For B3-MED, the project advances the company's core mission — building tools that help people make health decisions based on scientific data rather than advertising promises.

KremIQ is also helping B3-MED extend its reach into the fast-growing sectors of beauty, dermatology, and cosmetology.